Rifkin-Zenenberg, S., Kanter, J., Kinney, M. A., Kwiatkowski, J. L., Nickel, R. S., Walters, M. C., … Gupta, A. O. (2024). An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel. In Blood (Vol. 144, pp. 511–511). American Society of Hematology. https://doi.org/10.1182/blood-2024-199743

Rifkin-Zenenberg, Stacey, Julie Kanter, Melissa A. Kinney, Janet L. Kwiatkowski, Robert S. Nickel, Mark C. Walters, Suhag Parikh, et al. “An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel.” In Blood, 144:511–511. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-199743.

Rifkin-Zenenberg S, Kanter J, Kinney MA, Kwiatkowski JL, Nickel RS, Walters MC, et al. An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel. In: Blood. American Society of Hematology; 2024. p. 511–511.

Rifkin-Zenenberg, Stacey, et al. “An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel.” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 511–511. Crossref, doi:10.1182/blood-2024-199743.

Rifkin-Zenenberg S, Kanter J, Kinney MA, Kwiatkowski JL, Nickel RS, Walters MC, Parikh S, Thompson A, George AP, Mapara M, Martin PL, Chawla A, Lodaya A, Pan L, Sheldon-Waniga E, Pierciey FJ, Tisdale J, Gupta AO. An Update on Lovotibeglogene Autotemcel (Lovo-cel) Clinical Trials for Sickle Cell Disease (SCD) and Analysis of Early Predictors of Response to Lovo-Cel. Blood. American Society of Hematology; 2024. p. 511–511.